Koumpis E, Georgoulis V, Papathanasiou K, Papoudou-Bai A, Kanavaros P, Kolettas E
Biomedicines. 2025; 12(12.
PMID: 39767565
PMC: 11673977.
DOI: 10.3390/biomedicines12122658.
Gao K, Zhou T, Yin Y, Sun X, Jiang H, Li T
Hereditas. 2024; 161(1):54.
PMID: 39726023
PMC: 11670371.
DOI: 10.1186/s41065-024-00349-5.
Singh A, Prabhu J, Vanni S
Nano Lett. 2024; 25(1):77-83.
PMID: 39719269
PMC: 11719626.
DOI: 10.1021/acs.nanolett.4c04153.
Zhu J, Xiao H, Li C, Li X, Zheng J, Yao X
Cancer Biol Ther. 2024; 25(1):2429175.
PMID: 39564935
PMC: 11581179.
DOI: 10.1080/15384047.2024.2429175.
Aguirre M, Long K, Li N, Manoto S, Cunningham B
Chemosensors (Basel). 2024; 6(2).
PMID: 39559408
PMC: 11573240.
DOI: 10.3390/chemosensors6020013.
Focus on Achalasia in the Omics Era.
Brina A, Palmieri O, Cannarozzi A, Tavano F, Guerra M, Bossa F
Int J Mol Sci. 2024; 25(18).
PMID: 39337632
PMC: 11431880.
DOI: 10.3390/ijms251810148.
The Application of Molecular Techniques for Assessment of SOX2 and miR126 Expression as Prognostic Markers in Esophageal Carcinoma.
Gharib A, Elsawy W, Alrehaili A, Amin H, Alhuthali H, Bakhuraysah M
Comput Math Methods Med. 2024; 2022:1514412.
PMID: 39290848
PMC: 11407893.
DOI: 10.1155/2022/1514412.
Gra-CRC-miRTar: The pre-trained nucleotide-to-graph neural networks to identify potential miRNA targets in colorectal cancer.
Yin R, Zhao H, Li L, Yang Q, Zeng M, Yang C
Comput Struct Biotechnol J. 2024; 23:3020-3029.
PMID: 39171252
PMC: 11338065.
DOI: 10.1016/j.csbj.2024.07.014.
CRISPR-Cas9 genome and long non-coding RNAs as a novel diagnostic index for prostate cancer therapy via liposomal-coated compounds.
Kadry M, Abdel-Megeed R
PLoS One. 2024; 19(5):e0302264.
PMID: 38723038
PMC: 11081254.
DOI: 10.1371/journal.pone.0302264.
Gra-CRC-miRTar: The pre-trained nucleotide-to-graph neural networks to identify potential miRNA targets in colorectal cancer.
Yin R, Zhao H, Li L, Yang Q, Zeng M, Yang C
bioRxiv. 2024; .
PMID: 38659732
PMC: 11042274.
DOI: 10.1101/2024.04.15.589599.
Noncoding RNA landscape and their emerging roles as biomarkers and therapeutic targets in meningioma.
Joshi R, Sharma A, Kulshreshtha R
Mol Ther Oncol. 2024; 32(1):200782.
PMID: 38596289
PMC: 10951709.
DOI: 10.1016/j.omton.2024.200782.
ThermomiR-377-3p-induced suppression of Cirbp expression is required for effective elimination of cancer cells and cancer stem-like cells by hyperthermia.
Lin T, Jia J, Luo W, Lin X, Xiao S, Yang J
J Exp Clin Cancer Res. 2024; 43(1):62.
PMID: 38419081
PMC: 10903011.
DOI: 10.1186/s13046-024-02983-3.
Value of negatively correlated miR-205-5p/ and miR-96-5p/ on the diagnosis of breast cancer and benign breast diseases.
Li J, Peng S, Zou X, Geng X, Wang T, Zhu W
Cancer Pathog Ther. 2024; 1(3):159-167.
PMID: 38327836
PMC: 10846318.
DOI: 10.1016/j.cpt.2023.04.002.
MiR-34a functions as a tumor suppressor in oral cancer through the inhibition of the Axl/Akt/GSK-3β pathway.
Su Y, Lin C, Shen P, Chuang S, Dai Y, Huang T
J Dent Sci. 2024; 19(1):428-437.
PMID: 38303867
PMC: 10829669.
DOI: 10.1016/j.jds.2023.08.013.
A common molecular and cellular pathway in developing Alzheimer and cancer.
Ali M, Wani S, Dey T, Sridhar S, Qadrie Z
Biochem Biophys Rep. 2024; 37:101625.
PMID: 38225990
PMC: 10788207.
DOI: 10.1016/j.bbrep.2023.101625.
mA-mediated lncRNA MAPKAPK5-AS1 induces apoptosis and suppresses inflammation via regulating miR-146a-3p/SIRT1/NF-κB axis in rheumatoid arthritis.
Wen J, Liu J, Wan L, Jiang H, Xin L, Sun Y
Cell Cycle. 2024; 22(23-24):2602-2621.
PMID: 38225924
PMC: 10936687.
DOI: 10.1080/15384101.2024.2302281.
Near-Infrared Induced miR-34a Delivery from Nanoparticles in Esophageal Cancer Treatment.
Alden N, Yeingst T, Pfeiffer H, Celik N, Arrizabalaga J, Helton A
Adv Healthc Mater. 2024; 13(10):e2303593.
PMID: 38215360
PMC: 11032112.
DOI: 10.1002/adhm.202303593.
Increased hsa-miR-100-5p Expression Improves Hepatocellular Carcinoma Prognosis in the Asian Population with Variant rs27770A>G.
Liao Z, Zhang Q, Yang L, Li H, Mo W, Song Z
Cancers (Basel). 2024; 16(1).
PMID: 38201556
PMC: 10778516.
DOI: 10.3390/cancers16010129.
Association of microRNA Polymorphisms with Toxicities Induced by Methotrexate in Children with Acute Lymphoblastic Leukemia.
Karpa V, Kalinderi K, Fidani L, Tragiannidis A
Hematol Rep. 2023; 15(4):634-650.
PMID: 37987321
PMC: 10660515.
DOI: 10.3390/hematolrep15040065.
MicroRNAs as potential biopredictors for premenopausal osteoporosis: a biochemical and molecular study.
Al-Rawaf H, Gabr S, Iqbal A, Alghadir A
BMC Womens Health. 2023; 23(1):481.
PMID: 37689658
PMC: 10493018.
DOI: 10.1186/s12905-023-02626-3.
